Research graph
References from ABO-identical versus incompatible platelet transfusion in patients with intracranial hemorrhage. Local targets link to admitted publications; unresolved targets remain external evidence.
Routine platelet transfusion in patients with traumatic intracranial hemorrhage taking antiplatelet medication: Is it warranted?
10.1503/cjs.018120 · 2022 · External reference
Thrombocytopenia and Clinical Outcomes in Intracerebral Hemorrhage: A Retrospective Multicenter Cohort Study
10.1161/strokeaha.120.031478 · 2021 · External reference
Platelet transfusion in patients with aneurysmal subarachnoid hemorrhage is associated with poor clinical outcome
10.1038/s41598-020-57683-7 · 2020 · External reference
The Role of Platelet Transfusions After Intracranial Hemorrhage in Patients on Antiplatelet Agents: A Systematic Review and Meta-Analysis
10.1016/j.wneu.2020.03.216 · 2020 · External reference
Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial
10.1016/s0140-6736(16)30392-0 · 2016 · External reference
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association
10.1161/str.0000000000000407 · 2022 · External reference
Platelet transfusion: a clinical practice guideline from the AABB
10.7326/m14-1589 · 2015 · External reference
Does ABO and RhD matching matter for platelet transfusion?
10.1182/hematology.2020000135 · 2020 · External reference
Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility
10.4103/0973-6247.162684 · 2015 · External reference
Platelet Transfusions: The Good, the Bad, and the Ugly
10.1213/ane.0000000000006918 · 2024 · External reference
Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients
10.1182/blood-2003-08-2724 · 2005 · External reference
Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage
10.1182/blood.2020008381 · 2021 · External reference
Assessment of outcome after severe brain damage
10.1016/s0140-6736(75)92830-5 · 1975 · External reference
Interobserver agreement for the assessment of handicap in stroke patients
10.1161/01.str.19.5.604 · 1988 · External reference
PATCH trial: explanatory analyses
10.1182/blood.2019003298 · 2020 · External reference
Survey evaluating clinical equipoise around platelet transfusion after head injury and traumatic intracranial haemorrhage (ICH) in patients on antiplatelet medications
10.1136/emermed-2021-211189 · 2022 · External reference
Prophylactic platelet transfusion response in critically ill patients: a prospective multicentre observational study
10.1186/s13054-023-04650-z · 2023 · External reference
Isolated platelet concentrate transfusion during surgery: a single-center observational cohort study
10.1111/trf.15156 · 2019 · External reference
Recommended Primary Outcomes for Clinical Trials Evaluating Hemostatic Agents in Patients With Intracranial Hemorrhage: A Consensus Statement
10.1001/jamanetworkopen.2021.23629 · 2021 · External reference
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial
10.1182/blood-2018-02-831289 · 2018 · External reference
Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial
10.1001/jamaoncol.2017.5123 · 2018 · External reference
Efficacy and Safety of Pathogen-Reduced Platelets Compared with Standard Apheresis Platelets: A Systematic Review of RCTs
10.3390/pathogens11060639 · 2022 · External reference
